Drugs for the Poor
TROPICAL fevers often leave their victims running hot and cold. Critics of the pharmaceutical industry argue that drugmakers behave in much the same w...
TROPICAL fevers often leave their victims running hot and cold. Critics of the pharmaceutical industry argue that drugmakers behave in much the same w...
The Alliance is convening a core group of leading scientists after this week's Keystone meeting on TB Genomics to assess how the latest science, i...
The Global Alliance for TB Drug Development (TB Alliance) applauds yesterday’s announcement from Gates Foundation to establish the Grand Challen...
Today's most urgent global public health crises - the alarming progress of AIDS, tuberculosis, and malaria - confront our medical comm...
Bay Area biotech leaders are in the forefront of a movement to teach our profit-driven drug development industry how to make medicines for the world...
Two stakeholders of the TB Alliance are partnering to establish a South African Clinical Trials Consortium with an emphasis on TB-HIV and MDR-TB. The...
The TB Alliance Stakeholders Meeting was held in conjunction with the annual International Union Against Tuberculosis and Lung Disease (IUATLD) confer...
The TB Alliance Scientific Advisory Committee (SAC) reviewed progress and outlined future research directions for the ongoing R&D strategy of the ...
The International Union Against Tuberculosis and Lung Disease (IUATLD), one of the TB Alliance Stakeholders, hosted its annual World Conference on Lun...
...